Articles > Tandem
Last month, the FDA approved the Tandem Diabetes Care update to its t:slim X2 insulin pump Control-IQ technology, clearing the way for the first automated and interoperable insulin dosing system on the U.S. market.
A new study published in the New England Journal of Medicine (NEJM) showed promising results for closed-loop insulin delivery systems, the journal and participating manufacturers reported last week.
When I heard that Glu was having an event in NYC, I knew I couldn’t pass up on the opportunity to attend. The event was to discuss and inform fellow T1Ds and healthcare providers about Tandem Diabetes Care’s t:slim® Insulin Pump as well as educate people more on what Glu is as part of T1D […]
Have you heard of Human Factors research? As a practice in the development of medical devices, it’s become increasingly important, and plays a significant role in FDA’s assessment of new products. It combines a variety of disciplines to optimize a person’s experience in using devices and equipment. At our annual meeting in May, Noel Schaeffer, […]